MDS Abstracts

Abstracts from the International Congress of Parkinson’s and Movement Disorders.

MENU 
  • Home
  • Meetings Archive
    • 2025 International Congress
    • 2024 International Congress
    • 2023 International Congress
    • 2022 International Congress
    • MDS Virtual Congress 2021
    • MDS Virtual Congress 2020
    • 2019 International Congress
    • 2018 International Congress
    • 2017 International Congress
    • 2016 International Congress
  • Keyword Index
  • Resources
  • Advanced Search
  • 2018 International Congress

    A Young Man with Multiple System Atrophy: A Case Report

    DR. Carneiro, M. Sousa, C. Januário, A. Morgadinho (Coimbra, Portugal)

    Objective: To describe the case of a young man with the diagnosis of probable Multiple System Atrophy. Background: MSA is a complex neurodegenerative disorder. The…
  • 2018 International Congress

    MSA Preliminary Panamerican Report

    M. Cesarini, E. Gatto, J. Etcheverry, G. Da Prat, N. Gonzalez Rojas, H. Teive, M. Rodriguez, J. Ziliani, M. Miranda, P. Chana, F. Cardoso, A. Cardozo, C. Uribe Roca, I. Amorin, L. Abaroa, c. Cosentino, Y. Nuñez, A. Lescano, E. Dieguez, A. Alleva, I. Litvan, G. Wenning (La Plata, Argentina)

    Objective: To report the results of the PAN American MSA (PANMSA) database Background: Multiple system atrophy (MSA) is a rare neurodegenerative disease and coordinated efforts…
  • 2018 International Congress

    The characteristic of gait in progressive progressive supranuclear palsy

    Y. Takamatsu, N. Matsuda, I. Aiba (Kyoto, Japan)

    Objective: ​To elucidate the characteristic of gait in patients with progressive supranuclear palsy (PSP) and compare to healthy elderly and patients with Parkinson’s disease (PD)…
  • 2018 International Congress

    [18F]FP-CIT and [18F]FDG PET findings in MSA patients with cognitive impairment

    KB. Lee, YJ. Park, C. Lee (Seoul, Republic of Korea)

    Objective: We investigated the brain dopaminergic system and glucose metabolism in multiple system atrophy (MSA) patients with cognitive impairment. Background: Since the first report of…
  • 2018 International Congress

    A case of levodopa responsive rapid onset dystonia-parkinsonism

    Y. Fernandez, S. Frucht (New York, NY, USA)

    Objective: We describe and demonstrate by video a young man with rapid onset dystonia parkinsonism who has a robust response to levodopa. Background: Rapid onset…
  • 2018 International Congress

    Oculomotor Behavior in Healthy Caribbean: Does it reflect an increased vulnerability to degenerative Parkinsonism?

    A. Lannuzel, A. Lackmy, B. Tressières, R. Edragas, V. Pélonde-Erimée, C. Bonnet, S. Rivaud-Péchoux, E. Roze, B. Gaymard (Pointe-à-Pitre, Guadeloupe)

    Objective: To investigate the impact of environmental factors on eye movement performances in two populations composed of carefully selected healthy subjects with strikingly different ethnic…
  • 2018 International Congress

    Spatial correlation and segregation of multimodal MRI abnormalities in multiple system atrophy

    J.H. Lee, M.J. Lee, T.H. Kim (Yangsan-si, Gyeongsangnam-do, Republic of Korea)

    Objective: This study aimed to quantify spatial patterns of multimodal MRI abnormalities in basal ganglia (BG) and brainstem-cerebellar (Stem-CB) regions and define structural MRI findings…
  • 2018 International Congress

    Revision of Diagnosis in Early Parkinsonism with Abnormal Dopamine Transporter Imaging: A Case Series from the PPMI Study

    J. Massa, L. Chahine (Pittsburgh, PA, USA)

    Objective: To describe the characteristics of patients initially diagnosed with idiopathic Parkinson’s Disease (PD) and with abnormal dopamine transporter (DAT) imaging who have a change…
  • 2018 International Congress

    Pupillary autonomic dysfunction and oculomotor characteristics of multiple system atrophy

    K.W. Park, EJ. Lee, N.R. Choi, M.S. Kim, S.J. Chung (Seoul, Republic of Korea)

    Objective: To investigate the pupillary autonomic function and oculomotor characteristics of patients with multiple system atrophy (MSA). Background: MSA is a debilitating neurodegenerative disorder with…
  • 2018 International Congress

    Motor and cognitive deficits in a mouse model of tauopathy with tau isoforms imbalance: Potential therapeutic strategies

    ME. Avale, SL. Espindola, A. Damianich, M. Sartor, J. Ferrario (Buenos Aires, Argentina)

    Objective: This work investigates motor phenotypes and neurochemical changes in a mouse model of tauopathy linked to tau mis-splicing. We sought to validate a potential…
  • « Previous Page
  • 1
  • …
  • 1286
  • 1287
  • 1288
  • 1289
  • 1290
  • …
  • 1734
  • Next Page »

Most Viewed Abstracts

  • This Month
  • All Time
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • Life expectancy with and without Parkinson’s disease in the general population
  • What is the appropriate sleep position for Parkinson's disease patients with orthostatic hypotension in the morning?
  • “Magic carpet for freezing of gait ” Evaluating a combination of patterned and pictographic visual cues.
  • Increased Risks of Botulinum Toxin Injection in Patients with Hypermobility Ehlers Danlos Syndrome: A Case Series
  • Effect of marijuana on Essential Tremor: A case report
  • Increased Risks of Botulinum Toxin Injection in Patients with Hypermobility Ehlers Danlos Syndrome: A Case Series
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • Help & Support
  • About Us
  • Cookies & Privacy
  • Wiley Job Network
  • Terms & Conditions
  • Advertisers & Agents
Copyright © 2025 International Parkinson and Movement Disorder Society. All Rights Reserved.
Wiley